NCT00493350View on ClinicalTrials.gov

Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer

CompletedOBSERVATIONAL

Enrollment

660

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Breast Cancer

Interventions

PROCEDURE

Blood Sample

1x4 ml (Serum Tube); 2x10 ml (CellSave Tube); 1x10 ml EDTA (Selected Centers)

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Janssen Diagnostics, LLC

All Listed Sponsors

collaborator

Janssen Diagnostics, LLC

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT00493350 - Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter